May 2022: In This Issue

For women in rural populations, access to education and care is limited, causing disparities in diabetes care.

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.

The therapy is the first and only oral direct acting antiviral approved by the FDA for HCV infection.

In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.

Investigators find that patients with moderate weight loss or those who were weight resistant still had improvement in cardiometabolic health.

Investigators find that the risk for new-onset diabetes is especially prominent for patients aged 20 to 29 years.